Burton Christopher, Cameron Isobel, Anderson Niall
Division of Applied Medicine, University of Aberdeen, Aberdeen.
Centre for Population Health Sciences, University of Edinburgh, Edinburgh.
Br J Gen Pract. 2015 Feb;65(631):e114-20. doi: 10.3399/bjgp15X683557.
Practices vary in the duration of newly initiated antidepressant treatment, even after adjusting for patient characteristics. It was hypothesised that this may be because of differences between practices in demographic (practice deprivation and antidepressant prescribing rates), organisational (practice size and proportion of female GPs), and clinical factors (proportion of new episodes of depression coded).
To examine the effect of practice characteristics on the duration of new selective serotonin reuptake inhibitor antidepressant treatment in primary care.
Database cohort study of 28 027 patients from 237 GP practices in Scotland.
Prescription data were used to estimate duration of treatment for individual patients beyond three time points: 30, 90, and 180 days. Data at patient and practice level were analysed by multilevel logistic regression to quantify the variation between practices.
The mean rate of diagnostic coding for depression in patients beginning a course of treatment was 29% (range 0-80%). Practice-level deprivation and rate of new antidepressant prescribing were not associated with duration of treatment. The practice level factor most strongly associated with duration of treatment at practice level was the proportion of patients coded as having depression: odds ratio for continuing beyond 30 days was 1.54 (95% confidence interval [CI] = 1.22 to 1.94); beyond 90 days, 1.37 (95% CI = 1.09 to 1.71); and beyond 180 days 1.41 (95% CI = 1.10 to 1.82).
Encouraging coding and structured follow-up at the onset of treatment of depression is likely to reduce early discontinuation of antidepressant treatment and improve outcomes.
即使在对患者特征进行调整之后,新开始的抗抑郁药物治疗疗程的时长在不同医疗机构中仍存在差异。据推测,这可能是由于不同医疗机构在人口统计学因素(机构贫困程度和抗抑郁药物处方率)、组织因素(机构规模和女性全科医生比例)以及临床因素(编码的新发抑郁症发作比例)方面存在差异。
研究医疗机构特征对基层医疗中新的选择性5-羟色胺再摄取抑制剂抗抑郁药物治疗疗程时长的影响。
对来自苏格兰237家全科医生诊所的28027名患者进行数据库队列研究。
使用处方数据估算个体患者在三个时间点(30天、90天和180天)之后的治疗时长。通过多水平逻辑回归分析患者和医疗机构层面的数据,以量化不同医疗机构之间的差异。
开始治疗疗程的患者中抑郁症诊断编码的平均比例为29%(范围为0 - 80%)。医疗机构层面的贫困程度和新抗抑郁药物处方率与治疗时长无关。在医疗机构层面,与治疗时长最密切相关的因素是被编码为患有抑郁症的患者比例:超过30天继续治疗的优势比为1.54(95%置信区间[CI]=1.22至1.94);超过90天为1.37(95%CI = 1.09至1.71);超过180天为1.41(95%CI = 1.10至1.82)。
在抑郁症治疗开始时鼓励进行编码和结构化随访可能会减少抗抑郁药物治疗的早期停药情况并改善治疗效果。